1h Free Analyst Time
The progesterone market is forecasted to grow by USD 1.24 billion during 2023-2028, accelerating at a CAGR of 13% during the forecast period. The report on the progesterone market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of breast cancer, technological advancements in field of drug delivery, and robust drug pipeline.
The progesterone market is segmented as below:
By Type
- Synthetic progesterone
- Natural progesterone
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the progesterone market covers the following areas:
- Progesterone Market sizing
- Progesterone Market forecast
- Progesterone Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global progesterone market: AbbVie Inc., Alkem Laboratories Ltd., Aquatic Group, Bionpharma Inc., Blubell Pharma Group, Cadila Pharmaceuticals Ltd., Caesar and Loretz GmbH, Cipla Inc., Dr Reddys Laboratories Ltd., Estrellas Life Sciences Pvt. Ltd., Fagron NV, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Kiama Lifesciences, Lupin Ltd., Organon and Co., PROCAPS S.A, Teva Pharmaceutical Industries Ltd., and Virtus Pharmaceuticals LLC.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in research and development of progesterone drugs."
According to the report, one of the major drivers for this market is the increasing prevalence of breast cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Alkem Laboratories Ltd.
- Aquatic Group
- Bionpharma Inc.
- Blubell Pharma Group
- Cadila Pharmaceuticals Ltd.
- Caesar and Loretz GmbH
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- Estrellas Life Sciences Pvt. Ltd.
- Fagron NV
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals Plc
- Intas Pharmaceuticals Ltd.
- Kiama Lifesciences
- Lupin Ltd.
- Organon and Co.
- PROCAPS S.A
- Teva Pharmaceutical Industries Ltd.
- Virtus Pharmaceuticals LLC
